Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.305 USD | -12.86% | 0.00% | -40.20% |
02/04 | CYduct Diagnostics, Inc. Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer | CI |
2021 | CYduct Diagnostics, Inc. announced a financing transaction | CI |
Sales 2010 | 4L 3.58Cr | Sales 2011 | 3L 2.74Cr | Capitalization | 4L 3.3Cr |
---|---|---|---|---|---|
Net income 2010 | -10L -8.34Cr | Net income 2011 | - 0 | EV / Sales 2010 | 0.87 x |
Net Debt 2010 | 3L 2.21Cr | Net Debt 2011 | 2L 1.39Cr | EV / Sales 2011 | 1.71 x |
P/E ratio 2010 * |
-
| P/E ratio 2011 |
-
| Employees | 4 |
Yield 2010 * |
-
| Yield 2011 |
-
| Free-Float | 0% |
1 day | -12.86% | ||
Current month | +1.67% | ||
1 month | +1.67% | ||
3 months | -25.61% | ||
6 months | -40.20% | ||
Current year | -40.20% |
Managers | Title | Age | Since |
---|---|---|---|
Dominick Gatto
CEO | Chief Executive Officer | 63 | 15/17/15 |
Claus Madsen
DFI | Director of Finance/CFO | - | - |
Michael Stewart
COO | Chief Operating Officer | 66 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Stewart
COO | Chief Operating Officer | 66 | - |
Dominick Gatto
CEO | Chief Executive Officer | 63 | 15/17/15 |
- Stock Market
- Equities
- CYDX Stock